Invest Guatemala at CPHI Barcelona

Boosting Investment in the Guatemalan Pharmaceutical Industry

In an effort to strengthen Guatemala’s presence in the global pharmaceutical arena, the private investment promotion agency, Invest Guatemala, along with ZOLIC, recently participated in the most important business fair in this industry, CPHI Barcelona. During this prominent event, our team held key meetings with some of the world’s most influential pharmaceutical companies. The main objective was to present the extensive foreign investment opportunities offered by the Guatemalan industry, highlighting, in particular, the advantages of nearshoring to access the United States market.

Investment Opportunities Presentation

Invest Guatemala seized the platform at CPHI Barcelona to highlight the competitive advantages that Guatemala offers as an investment destination in the pharmaceutical industry. Guatemala has experienced sustained growth in its pharmaceutical manufacturing sector, supported by a robust infrastructure, favorable government policies, and a skilled workforce.

Nearshoring to the United States

One of the crucial points in our discussions was the nearshoring potential that Guatemala presents for pharmaceutical companies aiming to access the U.S. market. Guatemala’s strategic location, proximity to the United States, and its involvement in key trade agreements and free trade treaties make it an attractive option for companies looking to optimize their supply chains and reduce logistical costs.

Establishment of Strategic Alliances

During the fair, Invest Guatemala not only presented data and statistics but also explored opportunities to establish strategic alliances with global pharmaceutical companies. These alliances have the potential to generate significant collaborations that will benefit both the Guatemalan industry and foreign companies interested in expanding their presence in Latin America.

Recognition of Local Achievements

Throughout our meetings, we highlighted the notable achievements of the Guatemalan pharmaceutical industry, including advancements in clinical research, adoption of innovative technologies, and compliance with international quality standards. These successes underscore Guatemala’s ability to compete globally, providing investors with the necessary confidence to consider the country as a strategic partner.

Invest Guatemala’s participation in CPHI Barcelona marked a significant milestone in boosting the Guatemalan pharmaceutical industry on the international stage. Fruitful meetings with industry leaders open the door to new investment and collaboration opportunities, solidifying Guatemala as an attractive destination for nearshoring in the pharmaceutical sector. As we move forward, we look forward to building strong relationships that benefit both parties and contribute to the sustainable growth of the pharmaceutical industry in Guatemala.